Thomas W. Beetham
Chief Operating Officer · 2 filings · Latest: Mar 3, 2026
Viridian Therapeutics, Inc.\DE
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|
VRDN | Thomas W. Beetham | Chief Operating Officer | Mar 3, 2026 | Option Exercise | — | 9,409 | — | 16,409 | |
VRDN | Beetham Thomas W. | — | Mar 4, 2026 | Proposed Sale | $30.19 | 3,048 | $92.0K | — | |